Neurotrophic factors in Alzheimer's and Parkinson's disease brain

Brain Research Reviews

Volumn 33, Issue 2-3, 2000, Pages 199-227

  Siegel, George J ^a   Chauhan, Neelima B ^b,c  

^a Neurology Service (127)   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Aging; Alzheimer's disease; Neurotrophic factor; Parkinson's disease; Receptors

Indexed keywords

ARTEMIN; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN RECEPTOR; NEURTURIN; PERSEPHIN;

AGE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL TYPE; EPILEPSY; GLIA CELL; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; NERVE FIBER TRANSPORT; NONHUMAN; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SUBSTANTIA NIGRA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BRAIN CHEMISTRY; HUMANS; NERVE GROWTH FACTORS; PARKINSON DISEASE; RECEPTORS, NERVE GROWTH FACTOR;

EID: 0033813571     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(00)00030-8     Document Type: Review

References (243)

1. Aebischer P., Schluep M., Deglon N., Joseph J.M., Hirt L., Heyd B., Goddard M., Hammang J.P., Zurn A.D., Kato A.C., Regli F., Baetge E.E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 6:1996;696-699. Published erratum appears in Nat. Med. Sep; 2(9) (1996) 1041.
2. Aguado F., Ballabriga J., Pozas E., Ferrer I. TrkA immunoreactivity in reactive astrocytes in human neurodegenerative diseases and colchicine-treated rats. Acta Neuropathol. (Berl.). 96:(5):1998;495-501.
3. Aguado F., Majo G., Gomez de Aranda I., Ferrer I. Trk neurotrophin receptor family immunoreactivity in rat and human pituitary tissues. Neurosci. Lett. 243:(1-3):1998;13-16.
4. Aigner T.G., Mitchell S.J., Aggleton J.P., DeLong M.R., Struble R.G., Price D.L., Wenk G.L., Mishkin M. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacology. 92:1987;292-300.
5. Akira S. IL-6 regulated transcription factors. Int. J. Biochem. Cell Biol. 29:(12):1997;1401-1418.
6. Alberti L., Borrello M.G., Ghizzoni S., Torriti F., Rizzetti M.G., Pierotti M.A. Grb2 binding to the different isoforms of Ret tyrosine kinase. Oncogene. 17:(9):1998;1079-1087.
7. Alderson R.F., Pearsall D., Lindsay R.M., Wong V. Characterization of receptors for ciliary neurotrophic factor on rat hippocampal astrocytes. Brain Res. 818:(2):1999;236-251.
8. Allen S.J., Wilcox G.K., Dawbarn D. Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. Biochem. Biophys. Res. Comm. 264:(3):1999;648-651.
9. Aloyz R.S., Bamji S.X., Pozniak C.D., Toma J.G., Atwal J., Kaplan D.R., Miller F.D. P53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell Biol. 143:(6):1998;1691-1703.
10. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology. 46:((5)):1996;1244-1249.
11. Altar C.A., Boylan C.B., Fritsche M., Jackson C., Hyman C., Lindsay R.M. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp. Neurol. 30:(1):1994;31-40.
12. Altar C.A., Distefano P.S. Neurotrophin trafficking by anterograde transport. Trends Neurosci. 21:(10):1998;433-437.
13. Althaus H.H., Hempel R., Kloppner S., Engel J., Schmidt-Schultz T., Kruska L., Heumann R. Nerve growth factor signal transduction in mature pig oligodendrocytes. J. Neurosci. Res. 50:(5):1997;729-742.
14. Amoureux M.C., Van Gool D., Herrero M.T., Dom R., Colpaert F.C., Pauwels P.J. Regulation of metallothionein-III (GIF) mRNA in the brain of patients with Alzheimer's disease is not impaired. Mol. Chem. Neuropathol. 32:(1-3):1997;101-121.
15. Anand P., Terenghi G., Birch R., Wellmer A., Cedarbaum J.M., Lindsay R.M., Williams-Chestnut R.E., Sinieropi D.V. Endogenous NGF and CNTF levels in human peripheral nerve injury. Neuroreport. 8:(8):1997;1935-1938.
16. Apfel S.C. Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Pathol. 9:(2):1999;393-413.
17. Apfel S.C., Kessler J.A., Adornato B.T., Litchy W.J., Sanders C., Rask C.A. Recombinant human nerve growth factor in the treatment of diabetic neuropathy. NGF Study Group. Neurology. 51:(3):1998;695-702.
18. Araujo D.M., Hilt D.C., Miller P.J., Wen D., Jiao S., Lapchak P.A. Ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways. Neuroscience. 80:(1):1997;9-16.
19. Arenas E., Persson H. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature. 367:(6461):1994;368-371.
20. Arenas E., Trupp M., Akerud P., Ibanez C.F. GDNF prevents the degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron. 15:1995;1465-1473.
21. Baloh R.H., Tansey M.G., Lampe P.A., Fahrner T.J., Enomoto H., Simburger K.S., Leitner M.L., Araki T., Johnson E.M. Jr., Milbrandt J. Artemin, a novel member of the GDNF-ligand family, supports peripheral and central neurons and signals through the GFRalpha-3-RET receptor complex. Neuron. 21:(6):1998;1291-1302.
22. Bar K.J., Saldanha G.J., Kennedy A.J., Facer P., Birch R., Carlsted T., Anand P. GDNF and its receptor component Ret in injured human nerves and dorsal root ganglia. Neuroreport. 9:(1):1998;43-47.
23. Bergman E., Kullberg S., Ming Y., Unfhake B. Upregulation of GFRalpha-1 and c-ret in primary sensory neurons and spinal motoneurons of aged rats. J. Neurosci. Res. 57:(2):1999;153-165.
24. Belluardo N., Blum M., Mudo G., Andbjer B., Fuxe K. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of rat. Neuroscience. 83:(3):1998;723-740.
25. Benisty S., Boissiere F., Faucheux B., Agid Y., Hirsch E.C. TrkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study. Neuroscience. 86:(3):1998;813-826.
26. Besser M., Wank R. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J. Immunol. 162:(11):1999;6303-6306.
27. Bibel M., Hoppe E., Barde Y.A. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J. 18:(3):1999;616-622.
28. Bilak M.M., Shifrin D.A., Corse A.M., Bilak S.R., Kuncl R.W. Neuroprotective utility and neurotrophic action of nurturing in postnatal motor neurons: Comparison with GDNF and Persephin. Mol. Cell. Neurosci. 13:(5):1999;326-336.
29. Blesch A., Grill R.J., Tuszynski M.H. Neurotrophin gene therapy in CNS models of trauma and degeneration. Van Leeuwen F.W., Salchi A., Giger R.J., Holtmaat A.J.G.D., Verhaagen J. Progress in Brain Research. 117:1998;473-484 Elsevier Science BV.
30. Boissiere F., Faucheux B., Agid Y., Hirsch E.C. Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: An in situ hybridization study. Neurosci. Lett. 221:(2-3):1997;141-144.
31. Boissiere F., Faucheux B., Ruberg M., Agid Y., Hirsch E.C. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp. Neurol. 145:(1):1997;245-252.
32. Boissiere F., Hunot S., Faucheux B., Duyckaerts C., Hauw J.J., Agid Y., Hirsch E.C. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport. 8:(13):1997;2849-2852.
33. Bono F., Lamarche I., Bornia J., Savi P., Della Valle G., Herbert J.M. Nerve growth factor (NGF) exerts its pro-apoptotic effects via the p75NTR receptor in a cell cycle-dependent manner. FEBS Lett. 457:(1):1999;93-97.
34. Bowers W.J., Howard D.F., Federoff H.J. Gene therapeutic strategies for neuroprotection: Implications for Parkinson's disease. Exp. Neurol. 144:1997;58-68.
35. Bradford H.F., Zhou J., Pliego-Rivero B., Stern G.M., Jauniaux E. Neurotrophins in the pathogenesis and potential treatment of Parkinson's disease. Adv. Neurol. 80:1999;19-25.
36. Bredel M., Pollack I.F., Campbell J.W., Hamilton R.L. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high grade gliomas. Clin. Cancer Res. 3:(11):1997;2157-2164.
37. Brodeur G.M., Nakagawara A., Yamashiro D.J., Ikegaki N., Liu X.G., Azar C.G., Lee C.P., Evans A.E. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J. Neurooncol. 31:(1-2):1997;49-55.
38. Casper D., Mytilineou C., Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J. Neurosci. Res. 30:(2):1991;372-381.
39. Chao M., Casaccia-Bonnefil P., Carter B., Chittka A., Kong H., Yoon S.O. Neurotrophin receptors: mediators of life and death. Brain Res. Brain Res. Rev. 26:(2-3):1998;295-301.
40. Chauhan N.B., Lee J.M., Siegel G.J. Reductions in glial cell line-derived neurotrophic factor (GDNF) in substantia nigra neurons of Parkinson's disease brain. Soc. Neurosci. Abstr. 24:(1):1998;1465.
41. Chauhan N.B., Lee J.M., Siegel G.J. Selective depletion of glial cell line-derived neurotrophic factor (GDNF) in Parkinson's disease. Neurology. 52:(6):1999;A212-A213.
42. Chiariello M., Visconti R., Carlomagno F., Melillo R.M., Bucci C., de Franciscis V., Fox G.M., Jing S., Coso O.A., Gutkind J.S., Fusco A., Santoro M. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. Oncogene. 16:(19):1998;2435-2445.
43. Clarkson E.D., Zawada W.M., Freed C.R. GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell Tissue Res. 289:(2):1997;207-210.
44. Connor B., Beilharz E.J., Williams C., Synek B., Gluckman P.D., Faull R.L., Dragunow M. Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus. Brain Res. Mol Brain Res. 49:(1-2):1997;283-290.
45. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 27:1998;1-39.
46. Connor B., Young D., Lawlor P., Gai W., Waldvogel H., Faull R.L., Dragunow M. Trk receptor alterations in Alzheimer's disease. Mol. Brain Res. 42:(1):1996;1-17.
47. Corse A.M., Bilak M.M., Bilak S.R., Lehar M., Rothstein J.D., Kunel R.W. Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration. Neurobiol. Dis. 6:(5):1999;335-346.
48. Croll S.D., Ip N.Y., Lindsay R.M., Wiegand S.J. Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res. 812:(1-2):1998;200-208.
49. Crutcher K.A., Scott S.A., Liang S., Everson W.V., Weingartner J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J. Neurosci. 13:(6):1993;2540-2550.
50. J.L. Cummings, H.V. Vinters, G.M. Cole, Z.S. Khachaturian, Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51(Suppl 1) (1998) S2-S17, Discussion S65-S67.
51. Date I., Notter M.F.D., Felton S.Y., Felton D.L. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res. 526:1990;156-160.
52. Dechant G., Brade Y.A. Signalling through the neurotrophin receptor p75NTR. Curr. Opin. Neurobiol. 7:(3):1997;413-418.
53. Diaz Brinton R., Yamazaki R.S. Advances and challenges in the prevention and treatment of Alzheimer's disease. Pharm. Res. 15:(3):1998;386-398.
54. Dore S., Kar S., Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci. 20(8):1997;326-331.
55. Dugan L.L., Kim J.S., Zhang Y., Bart R.D., Sun Y., Holtzman D.M., Gutmann D.H. Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J. Biol. Chem. 274(36):1999;25842-25848.
56. Durbec P., Marcos-Gutierrez C.V., Kilkenny C., Grigoriou M., Wartiowaara K., Suvanto P., Smith D., Ponder B., Constantini F., Saarma M. GDNF signaling through the Ret receptor tyrosine kinase. Nature. 381:(6585):1996;789-793.
57. Durick K., Gill G.N., Taylor S.S. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. Mol. Cell Biol. 18:(4):1998;2298-2308.
58. Ebadi M., Bashir R.M., Heidrick M.L., Hamada F.M., Rafaey H.E., Hamed A., Helal G., Baxi M.D., Cerutis D.R., Lassim N.K. Neurotrophins and their receptors in nerve injury and repair. Neurochem. Int. 30:(4-5):1997;347-374.
59. Emmett C.J., Aswani S.P., Stewart G.R., Fairchild D., Johnson R.M. Dose-response comparison of recombinant human nerve growth factor and recombinant human basic fibroblast growth factor in the fimbria-fornix model of acute cholinergic degeneration. Brain Res. 673:(2):1995;199-207.
60. Emmett C.J., McNeeley P.A., Johnson R.M. Evaluation of human astrocytoma and glioblastoma cell lines for nerve growth factor release. Neurochem. Int. 30:(4-5):1997;465-474.
61. Engele J., Bohn M.C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11:1991;3070-3078.
62. Engele J., Frank B. Effects of glial cell-line derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP dependent signaling pathway. Cell Tissue Res. 286:(2):1996;235-240.
63. Enokido Y., de Sauvage F., Hongo J.A., Ninkina N., Rosenthal A., Buchman V.L., Davis A.M. GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Curr. Biol. 8:(18):1998;1019-1022.
64. Eriksdotter J.M., Nordberg A., Amberla K., Backman L., Ebendal T., Meyerson B., Olson L., Sieger S.M., Theodorsson E., Vitanene M., Winblad B., Wahlund L.O. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 9:(5):1998;246-257.
65. Federico G., Maremmani C., Cinquanta L., Baroncelli G.I., Fattori B., Saggese G. Mucus of the human olfactory epithelium contains the insulin-like growth factor-I system which is altered in some neurodegenerative diseases. Brain Res. 835:(2):1999;306-314.
66. Feng L., Wang C.Y., Jiang H., Oho C., Dugich-Djordjevic M., Mei L., Lu B. Differential signaling of glial cell line-derived neurothrophic factor and brain-derived neurotrophic factor in cultured ventral mesencephalic neurons. Neuroscience. 93:(1):1999;265-273.
67. Fenton H., Finch P.W., Rubin J.S., Rosenberg J.M., Taylor W.G., Kuo-Leblanc V., Rodriguez-Wolf M., Baird A., Schipper H.M., Stopa E.G. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res. 779:(1-2):1998;262-270.
68. Ferrer I., Ballabriga J., Marti E., Perez E., Alberch J., Arenas E. BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol. 8:(2):1998;253-261.
69. Ferrer I., Marin C., Rey M.J., Ribalta T., Goutan E., Blanco R., Tolosa E., Marti E. BDNF and full-length and truncated TrkB expression in Alzheimer's disease. Implications in therapeutic strategies. J. Neuropathol. Exp. Neurol. 58(7):1999;729-739.
70. Ferrer I., Marti E. Distribution of fibroblast growth factor receptor-1 (FGFR-1) and FGFR-3 in the hippocampus of patients with Alzheimer's disease. Neurosci. Lett. 240:(3):1998;139-142.
71. Fischer W., Wictorin K., Bjorklund A., Williams L.R., Varon S., Gage F.H. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 329:1987;65-68.
72. Franke B., Figiel M., Engele J. CNS glia are targets for GDNF and neurturin. Histochem. Cell Biol. 110:(6):1998;595-601.
73. Friedman W.J., Black I.B., Persson H., Ibanez C.F. Synergistic trophic actions on rat basal forebrain neurons revealed by a synthetic NGF/BDNF chimeric molecule. Eur. J. Neurosci. 7:(4):1995;656-662.
74. Frim D.M., Uhler T.A., Kern W.R., Beal M.F. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA. 91:1994;5104-5108.
75. Frolich L., Blum-Degen D., Riederer P., Hoyer S. A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann NY Acad. Sci. 893:1999;290-293.
76. Furukawa K., Guo Q., Schellenberg G.D., Mattson M.P. Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res. 52:(5):1998;618-624.
77. Gage F.H., Wolff J.A., Rosenberg M.B., Xu L., Yee J.K., Shults C., Friedman T. Grafting genetically modified cells to the brain: Possibilities for the future. Neuroscience. 23:1987;795-807.
78. Gash D.M., Gerhardt G.A., Hoffer B.J. Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates. Adv. Pharmacol. 42:1998;911-915.
79. Gash D., Zhang Z., Ovadia A., Cass W., Yi A., Simmerman L., Russel D., Martin D., Lapchak P., Collins F., Hoffer B., Gerhardt G. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
80. Gibbs R.B. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol. 151:(2):1998;289-302.
81. Giehl K.M., Schutte A., Mestres P., Yan Q. The survival promoting effect of glial cell line-derived neurotrophic factor on axotomized corticospinal neurons in vivo is mediated by an endogenous brain-derived neurotrophic factor mechanism. J. Neurosci. 18:(18):1998;7351-7360.
82. Golden J.P., Baloh R.H., Kotzbauer P.T., Lampe P.A., Osborne P.A., Milbrandt J.A., Johnson E.M. Jr. Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J. Comp. Neurol. 398:(1):1998;139-150.
83. Goldman S.A. Adult neurogenesis: from canaries to the clinic. J. Neurobiol. 36:(2):1998;267-286.
84. Glazner G.W., Mu X., Springer J.E. Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system. J. Comp. Neurol. 391:(1):1998;42-49.
85. Grimes M.L., Zhou J., Beattie E.C., Yuen E.C., Hall D.E., Valletta J.S., Topp K.S., LaVail J.H., Bunnett N.W., Mobley W.C. Endocytosis of activated TrkA: Evidence that nerve growth factor induces formation of signaling endosomes. J. Neurosci. 16:(24):1996;7950-7964.
86. Guo X., Chandrasekaran V., Lein P., Kaplan P.L., Higgins D. Leukemia inhibitory factor and ciliary neurotrophic factor cause dendritic retraction in cultured rat sympathetic neurons. J. Neurosci. 19:(6):1999;2113-2121.
87. Guo Q., Sebastian L., Sopher B.L., Miller M.W., Glazner G.W., Ware C.B., Martin G.M., Mattson M.P. Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proc. Natl. Acad. Sci. USA. 96:(7):1999;4125-4130.
88. Haass C., Kahle P.J. Parkinson's pathology in a fly. Nature. 404:(6776):2000;341-343.
89. Haller M.F., Saltzman W.M. Nerve growth factor delivery systems. J. Control. Release. 53:(1-3):1998;1-6.
90. Hashimoto Y., Abiru Y., Nishio C., Hatanaka H. Synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor on cultured basal forebrain cholinergic neurons from postnatal 2-week-old rats. Brain Res. Dev. Brain Res. 115:(1):1999;25-32.
91. Heese K., Hock C., Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70:(2):1998;699-707.
92. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6:1994;2155-2162.
93. Hellweg R., Gericke C.A., Jendroska K., Hartung H.D., Cervos-Navarro J. NGF content in the cerebral cortex of non-demented patients with amyloid plaques and in symptomatic Alzheimer's disease. Int. J. Dev. Neurosci. 16:(7-8):1998;787-794.
94. Hetman M., Kanning K., Cavanaugh J.E., Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274:(32):1999;22569-22580.
95. Hishiki T., Nimura Y., Isogai E., Kondo K., Ichimiya S., Nakamura Y., Ozaki T., Sakiyama S., Hirose M., Seki N., Takahashi H., Ohnuma N., Tanabe M., Nagakawara A. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2. Cancer Res. 58:(10):1998;2158-2165.
96. Ho A., Blum M. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice. Exp. Neurol. 148:(1):1997;348-359.
97. Hock C., Heese K., Muller-Spahn F., Hulette C., Rosenberg C., Otten U. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci. Lett. 241:(2-3):1998;151-154.
98. C. Hock, K. Heese, C. Hulette, C. Rosenberg, U. Otten, Region-specific neurotrophin imbalances in Alzheimer's disease: Decreased levels of BDNF and increased levels of NGF in hippocampus and cortical areas. Arch. Neurol., in press.
99. Hoffer B., Olson L. Treatment strategies for neurodegenerative diseases based on trophic factors and cell transplantation techniques. J. Neural Transm., Suppl. 49:1997;1-10.
100. Horellou P., Mallet J. Gene therapy for Parkinson's disease. Mol. Neurobiol. 15:(2):1997;241-256.
101. Horger B.A., Nishimura M.C., Armanini M.P., Wang L.C., Poulson K.T., Rosenblad C., Kirik D., Moffat B., Simmons L., Johnson E. Jr., Milbrandt J., Rosenthal A., Bjorklund A., Vandlen R.A., Hynes M.A., Phillips H.S. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 18:(13):1998;4929-4937.
102. Horton A.R., Barlett P.F., Pennica D., Davies A.M. Cytokines promote the survival of mouse cranial sensory neurons at different developmental stages. Eur. J. Neurosci. 10:(2):1998;673-679.
103. Hudgins S.N., Levison S.W. Ciliary neurotrophic factor stimulates astroglial hypertrophy in vivo and in vitro. Exp. Neurol. 150:(2):1998;171-182.
104. Hunot S., Bernard V., Fauchex B. Glial cell-line derived neurotrophic factor (GDNF) gene expression in the human brain: a postmortem in situ hybridization study with special reference to Parkinson's disease. J. Neural Transm. 103:1996;1043-1052.
105. Hyman C., Hoffer M., Barde Y.A., Juhasz M., Yancopoulos G. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
106. Hyman C., Juhasz M., Jackson C., Wright P. Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
107. Hynes M., Poulson K., Armanini M., Berkemerer L., Phillips H., Rosenthal A. Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37:1994;144-154.
108. Ibanez C.F. Emerging themes in structural biology of neurotrophic factors. Trends Neurosci. 21:(10):1998;438-444.
109. Ip N.Y. The neurotrophins and neuropoietic cytokines: two families of growth factors acting on neural and hematopoietic cells. Ann. NY Acad. Sci. 840:1998;97-106.
110. Ip N.Y., Yancopoulos G.D. Ciliary neurotrophic factor and its receptor complex. Prog. Growth Factor Res. 4:1992;139-155.
111. Kang U.J. Potential gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies. Mov. Disord. 13 Suppl., 1:1998;59-72.
112. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189:(5):1999;865-870.
113. Kimura H., Tooyama I., McGeer P.L. Acidic FGF expression in the surroundings of senile plaques. Tohoku J. Exp. Med. 174:(3):1994;279-293.
114. Kleese L.J., Parada L.F. Trks: signal transduction and intracellular pathways. Microsc. Res. Tech. 45:(4-5):1999;210-216.
115. Knusel B., Burton L.E., Longo F.M., Mobley W.C., Koliatsos V.E., Price D.L., Hefti F. Trophic action of recombinant human nerve growth factor on cultured rat embryonic CNS cells. Exp. Neurol. 110:(3):1990;274-283.
116. Knusel B., Gao H. Neurotrophins and Alzheimer's disease. Life Sci. 58:(22):1996;2019-2027.
117. Knusel B., Hefti F. Trophic actions of IGF-I and IGF-II and insulin on cholinergic and dopaminergic brain neurons. Adv. Exp. Med. Biol. 293:1991;351-360.
118. Kokaia Z., Airaksinen M.S., Nanobashvili A., Larsson E., Kujamaki E., Lindvall O., Saarma M. GDNF family ligands and receptors are differentially regulated after brain insults in rat. Eur. J. Neurosci. 11:(4):1999;1202-1216.
119. Koliatsos V.E., Nauta H.J., Clatterbuck R.E., Holtzman D.M., Mobley W.C., Price D.L. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkeys. J. Neurosci. 10:1990;3801-3813.
120. Kordower J.H., Palfi S., Chen E.Y., Ma S.Y., Sendera T., Cochran E.J., Muson E.J., Penn R., Goetz C.G., Comella C.D. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann. Neurol. 46:(3):1999;419-424.
121. J.H. Kordower, Yaping-Chu, A.J. Maclennan, Ciliary neurotrophic factor receptor alpha-immunoreactivity in the monkey central nervous system, J. Comp. Neurol. 377(3) (1997) 365-380.
122. Kossman T., Hans V., Imhof H.G., Trentz O., Morganti-Kossman M.C. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713:(1-2):1996;143-152.
123. Kotzbauer P.T., Lampe P.A., Heuckeroth R.O., Golden J.P., Creedon D.J., Johnson E.M. Jr., Milbrandt J. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature. 384:(6608):1996;467-470.
124. + toxicity. EMBO J. 14:(4):1995;736-742.
125. Kumar S., Kahn M.A., Dinh L., de Vellis J. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo. J. Neurosci. Res. 54:(6):1998;754-765.
126. Kunugi G., Hattori M., Ueki A., Isse K., Hirasawa H., Nanko S. Possible association of missense mutation (Gly[-63]Glu) of the neurotrophin-3 gene with Alzheimer's disease in Japanese. Neurosci. Lett. 241:(1):1998;65-67.
127. Landreth G.E. Growth Factors. Siegel G.J., Agranoff B.W., Albers R.W., Fisher S.K., Uhler M.K. Basic Neurochemistry, Molecular, Cellular and Medical Aspects, Sixth Edition. 1999;384-396 Lippincott-Raven, Philadelphia, New York.
128. Lapchak P., Beck K., Raujo D., Irwin I., Langston J., Hefti F. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience. 53:1993;183-194.
129. Lapchak P.A., Jiao S.S., Miller P.J., Williams L.R., Cummins V., Inouye G., Matheson C.R., Yan Q. Pharmacological characterization of glial cell line-derived neurotrophic factor: implications of GDNF as a therapeutic molecule to treat neurodegenerative diseases. Cell Tissue Res. 286:1996;179-189.
130. Lau L.-f., Huganir R.L. Tyrosine Phosphorylation. Siegel G.J., Agranoff B.W., Albers R.W., Fisher S.K., Uhler M.K. Basic Neurochemistry, Molecular, Cellular and Medical Aspects, Sixth Edition. 1999;497-517 Lippincott-Raven, Philadelphia, New York.
131. Laurenzi M.A., Beccari T., Stenke L., Sjolinder M., Stinchi S., Lindgren J.A. Expression of mRNA encoding neurotrophins and neurotrophin receptors in human granulocytes and bone marrow cell-enhanced neurotrophin-4 expression induced by LTB4. J. Leukoc. Biol. 64:(2):1998;228-234.
132. Lee D.A., Gross L., Wittrock D.A., Windebank A.J. Localization and expression of ciliary neurotrophic factor (CNTF) in postmortem sciatic nerve from patients with motor neuron disease and diabetic neuropathy. J. Neuropathol. Exp. Neurol. 55:(8):1996;915-923.
133. Levi-Montalcini R., Skaper S.D., Dal Toso R., Petrelli L., Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 19:(11):1996;514-520.
134. Lin L-F.H., Doherty D.H., Lile J.D., Becktesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
135. Lindahl B., Westling C., Gimenez-Gallego G., Lindahl U., Salmivirta M. Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex. J Biol. Chem. 274:(43):1999;30631-30635.
136. Lindholm D. Models to study the role of neurotrophic factors in neurodegeneration. J. Neural Transm., Suppl. 49:1997;33-42.
137. Lindsay R.M., Wiegand S.J., Altar C.A., Distefano P.S. Neurotrophic factors: from molecule to man. Trends Neurosci. 17:1994;182-190.
138. Lorigados L., Pavon N., Serrano T., Robinson M.A. Nerve growth factor and neurological diseases. Rev. Neurol. 26:(153):1998;744-748.
139. MacPhee I., Baker P.A. Extended ceramide exposure activates the trkA receptor by increasing receptor homodimer formation. J. Neurochem. 72:(4):1999;1423-1430.
140. Marinelli L., Cammarata S., Nobbio L., Schenone A., Zaccheo D., Angelini G., Tabaton M. Tyrosine kinase A-nerve growth factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. Neurosci. Lett. 273:(1):1999;67-71.
141. Mathern G.W., Babb T.L., Micevych P.E., Blanco C.E., Pretorius J.K. Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus. Mol. Chem. Neuropathol. 30:(1-2):1997;53-76.
142. Masure S., Cik M., Pangalos M.N., Bonaventure P., Verhasselt P., Lesage A.S., Leysen J.E., Gordon R.D. Molecular cloning, expression and tissue distribution of glial cell line-derived neurotrophic factor family receptor alpha-3 (GFRalpha-3). Eur. J. Biochem. 251:(3):1998;622-630.
143. Melamed I., Kelleher C.A., Franklin R.A., Brodie C., Hempsted B., Kaplan D., Gelfand E.W. Nerve growth factor signal transduction in human B lymphocytes is mediated by gp140trk. Eur. J. Immunol. 26:(9):1996;1985-1992.
144. Melillo R.M., Barone M.V., Lupoli G., Cirafici A.M., Carlomagno F., Visconti R., Matoskova B., Di Fiore P.P., Vecchio G., Fusco A., Santoro M. Ret-mediated mitogenesis requires Src kinase activity. Cancer Res. 59:(5):1999;1120-1126.
145. Meyer M., Zimmer J., Seiler R.W., Widmer H.R. GDNF increases the density of cells containing calbindin but not of cells containing calretinin in cultured rat and human fetal nigral tissue. Cell Transplant. 8:(1):1999;25-36.
146. Middlemas D.S., Kihl B.K., Zhou J., Zhu X. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J. Biol. Chem. 274:(23):1999;16451-16460.
147. Milbrandt J., de Sauvage F.J., Fahrner T.J., Baloh R.H., Leitner M.L., Tansey M.G., Lampe P.A., Heuckeroth R.O., Kotzbauer P.T., Simburger K.S., Golden J.P., Davies J.A., Vejsada R., Kato A.C., Hynes M., Sherman D., Nishimura M., Wang L.C., Vandlen R., Moffat B., Klein R.D., Poulsen K., Gray C., Garces A., Johnson E.M. Jr, et al. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron. 20(2):1998;245-253.
148. Miller R.G., Bryan W.W., Dietz M.A., Munsat T.L., Petajan J.H., Smith S.A., Goodpasture J.C. Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis. Neurology. 47:(5):1996;1329-1331.
149. Millar R.G., Petajan J.H., Bryan W.W., Armon C., Barohn R.J., Goodpasture J.C., Hoagland R.J., Parry G.J., Ross M.A., Stromatt S.C. A placebo-controlled trial of recombitant human ciliary neuritrophic (rhCNTF) factor in amyotrophic lateral scelerosis. rhCNTF ALS Study Group. Ann. Neurol. 39:(2):1996;256-260.
150. Miyagi N., Kato S., Terasaki M., Aoki T., Sugita Y., Yamaguchi M., Shigemori M., Morimatsu M. Fibroblast growth factor-9 (glia-activating factor) stimulates proliferation and production of glial fibrillary acidic protein in human gliomas either in the presence or in the absence of the endogenous growth factor expression. Oncol. Rep. 6:(1):1999;87-92.
151. Moffett J., Kratz E., Myers J., Stachowiak E.K., Florkiewicz R.Z., Stachowiak M.K. Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity. Mol. Biol. Cell. 9:(8):1998;2269-2285.
152. Moga M.M., Duong T. P75 neurotrophin receptor immunoreactivity in the aged human hypothalamus. Neurosci. Lett. 231:(1):1997;9-12.
153. Mogi M., Harada M., Kondo T., Riedere P., Inagaki H., Minami M., Nagatsu T. Interleukin-1-beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients. Neurosci. Lett. 180:(2):1994;147-150.
154. Mogi M., Togari A., Kondo T., Mizuno Y., Komure O., Kuno S., Ichinose H., Nagatsu T. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci. Lett. 270:(1):1999;45-48.
155. Moreau E., Vilar J., Lelievre-Pegorier M., Merlet-Benichou C., Gilbert T. Regulation of c-ret expression by retinoic acid in rat metanephros: implications in nephron mass control. Am. J. Physiol. 275:(6 pt 2):1998;F938-F945.
156. Mufson E.J., Kroin J.S., Sendera T.J., Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57:1999;451-484.
157. Mufson E.J., Lavine N., Jaffar S., Kordower J.H., Quirion R., Saragovi H.U. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146(1):1997;91-103.
158. Mufson E.J., Li J.M., Sobreviela T., Kordower J.H. Decreased TrkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport. 81:(1):1996;25-29.
159. Murakami H., Iwashita T., Asai N., Iwata Y., Narumiya S., Takahashi M. Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130Cas mediated by Ret kinase. Oncogene. 18:(11):1999;1975-1982.
160. Murer M.G., Boissiere F., Yan Q., Hunot S., Villares J., Faucheux B., Agid Y., Hirsch E., Raisman-Vozari R. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience. 88:(4):1999;1015-1032.
161. Murphy M., Dutton R., Koblar S., Cheema S., Bartlett P. Cytokines which signal through the LIF receptor and their actions in the nervous system. Prog. Neurobiol. 52:(5):1997;355-378.
162. Mustafa A., Lannfelt L., Lilius L., Islam A., Winblad B., Adem A. Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dement Geriatr Cogn Disord. 10:(6):1999;446-451.
163. Nakamura S., Arima K., Haga S., Aizawa T., Motoi Y., Otsuka M., Ueki A., Ikeda K. Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques. Brain Res. 814:(1-2):1998;222-225.
164. Nakashima K., Wiese S., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Yoshida K., Kishimoto T., Sendtner M., Taga T. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J. Neurosci. 19:(13):1999;5429-5434.
165. Narisawa-Saito M., Wakabayashi K., Tsuji S., Takahashi H., Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport. 7:1996;2925-2928.
166. Naveilhan P., Baudet C., Mikaels A., Shen L., Westphal H., Ernfors P. Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic family receptor. Proc. Natl. Acad. Sci. USA. 95:(3):1998;1295-1300.
167. Nishio T., Furukawa S., Akiguchi I., Sunohara N. Medial nigral dopamine neurons have rich neurotrophin support in humans. Neuroreport. 9:(12):1998;2847-2851.
168. Nishio T., Sunohara N., Furukawa S. Neurotrophin switching in spinal motoneurons of amyotropic lateral sclerosis. Neuroreport. 9:(7):1998;1661-1665.
169. Nomoto S., Ito S., Yang L.X., Kiuchi K. Molecular cloning and expression analysis of GFR alpha-3, a novel cDNA related to GDNFR alpha and NTNR alpha. Biochem. Biophys. Res. Commun. 244:(3):1998;849-853.
170. Numan S., Seroogy K.B. Increased expression of trkB mRNA in rat caudate-putamen following 6-OHDA lesions of the nigrostriatal pathway. Eur. J. Neurosci. 9:(3):1997;489-495.
171. Ohiwa M., Murakami H., Iwashita T., Asai N., Iwata Y., Imai T., Funahashi H., Takagi H., Takahashi M. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations. Biochem. Biophys. Res. Commun. 237:(3):1997;747-751.
172. Panni M.K., Atkinson J., Sofroniew M.V. Leukemia inhibitory factor prevents loss of p75-nerve growth factor receptor immunoreactivity in medial septal neurons following fimbria-fornix lesions. Neuroscience. 89:(4):1999;1113-1121.
173. Parain K., Murer M.G., Yan Q., Faucheux B., Agid Y., Hirsch E., Raisman-Vozari R. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport. 10:(3):1999;557-561.
174. Penn R.D., Kroin J.S., York M.M., Cedarbaum J.M. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery. 40:(1):1997;94-99. discussion 99-100.
175. Perez-Navarro E., Arenas E., Marco S., Alberch J. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo. Eur. J. Neurosci. 11:(1):1999;241-249.
176. Phillips H.S., Jeanne M., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. 7:1991;695-702.
177. Pincus D.W., Keyoung H.M., Harrison-Restelli C., Goodman R.R., Fraser R.A., Edgar M., Sakakibara S., Okano H., Nedergaard M., Goldman S.A. Fibroblast growth factor-2/brain-derived neurotrophic factor-associated maturation of new neurons generated from adult human subependymal cells. Ann. Neurol. 43:(5):1998;576-585.
178. Porter A.C., Vaillancourt R.R. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene. 17:1998;1343-1352.
179. Poteryaev D., Titievsky A., Sun Y.F., Thomas-Crusells J., Lindahl M., Billaud M., Arumae U., Saarma M. GDNF triggers a novel ret-independent Src kinase family-coupled signaling via a GPI-linked GDNF receptor alpha1. FEBS Lett. 463:(1-2):1999;63-66.
180. Quartu M., Geic M., Del Fiacco M. Neurotrophin-like immunoreactivity in the human trigeminal ganglion. Neuroreport. 8:(16):1997;3611-3617.
181. Quartu M., Lai M.L., Del Fiacco M. Neurotrophin-like immunoreactivity in the human hippocampal formation. Brain Res. Bull. 48:(4):1999;375-382.
182. Reeben M., Laurikainen A., Hiltunen J.O., Castren E., Saarma M. The messenger RNAs for both glial cell line-derived neurotrophic factor receptors, c-ret and GDNFRalpha, are induced in the rat brain in response to kainate-induced excitation. Neuroscience. 83:(1):1998;151-159.
183. Riccio A., Pierchala B.A., Ciarallo C.L., Ginty D.D. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science. 277:(5329):1997;1097-1100.
184. Riva M.A., Molteni R., Lovati E., Fumagalli F., Rusnati M., Racagni G. Cyclic-AMP dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor. Mol. Pharmacol. 49:(4):1996;699-706.
185. Rosenblad C., Kirik D., Devaux B., Moffat B., Phillips H.S., Bjorklund A. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Eur. J. Neurosci. 11:(5):1999;1554-1566.
186. Rossner S., Ueberham U., Schliebs R., Perez-Polo J.R., Bigl V. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog. Neurobiol. 56:(5):1998;541-569.
187. Salehi A., Ocampo M., Verhaagen J., Swaab D.E. p75 neurotrophin receptor in the nucleus basalis of Meynert in relation to age, sex and Alzheimer's disease. Exp. Neurol. 161:(1):2000;245-258.
188. Salehi A., Verhaagen J., Dijkhuizen P.A., Swabb D.F. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75:(2):1996;373-387.
189. Salehi A., Verhaagen J., Swaab D.E. Neurotrophin receptors in Alzheimer's disease. Prog. Brain Res. 117:1998;71-89.
190. Santiard-Baron D., Gosset. Nicole A., Sinet P.M., Christen Y., Ceballos-Picot I. Identification of beta-amyloid-responsive genes by RNA differential display: early induction of a DNA damage-inducible gene, gadd45. Exp. Neurol. 158(1):1999;206-213.
191. Sauer H., Wong V., Bjorklund A. Brain-derived neurotrophic factor and neurotrophin-4/5 modify neurotransmitter-related gene expression in the 6-hydroxydopamine-lesioned rat striatum. Neuroscience. 65:(4):1995;927-933.
192. Sautter J., Sable M., Sommer C., Strecker S., Weidner N., Oertel W.H., Kiessling M. BDNF and TrkB expression in intrastriatal ventral mesencephalic grafts in a rat model of Parkinson's disease. J. Neural. Transm. 105:(2-3):1998;253-263.
193. Schaar D.G., Sieber B.A., Sherwood A.C., Dean D., Mendoza G., Ramakrishnan L., Dreyfus C.F., Black I.B. Multiple astrocyte transcripts encode nigral trophic factors in rat and human. Exp. Neurol. 130:(2):1994;387-393.
194. Schneider J.A. GM1 ganglioside and neurotrophic factors in the treatment of Parkinson's disease. Neurosci. News. 1:(1):1998;10-16.
195. Scott S.A., Mufson E.J., Weingartner J.A., Skau K.A., Crutcher K.A. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci. 15:(9):1995;6213-6221.
196. Sendera T.J., Ma S.Y., Jaffar S., Kozlowski P.B., Kordower J.H., Mawal Y., Saragovi H.U., Mufson E.J. Reduction in TrkA immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome. J. Neurochem. 74:(3):2000;1185-1196.
197. Smith D.E., Roberts J., Gage F.H., Tuszynski M.H. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc. Natl. Acad. Sci. USA. 96:(19):1999;10893-10898.
198. Snider W.D., Lichtman J.W. Are neurotrophins synaptotrophins? Mol. Cell. Neurosci. 7:1996;433-442.
199. Sobue G. Neurotrophic factors and their receptor expressions in human neuropathies. Rinsho Shinkeigaku. 37:(12):1997;1107-1108.
200. Sobue G., Yamamoto M., Doyu M., Li M., Yasuda T., Mitsuma T. Expression of mRNAs for neurotrophins (NGF, BDNF and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in human peripheral neuropathies. Neurochem. Res. 23:(6):1998;821-829.
201. Soontornniyomkij V., Wang G., Pittman C.A., Wiley C.A., Achim C.L. Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis. Neuropathol. Appl. Neurobiol. 24:(6):1998;453-460.
202. Springer J.E., Mu X., Bergman L.W., Trojanowski J.Q. Expression of GDNF mRNA in rat and human nervous tissue. Exp. Neurol. 127:(2):1994;167-170.
203. Steinbusch H.M., Vermeulen R.J., Tonnaer J.A. Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat caudate-putamen: preliminary observations. Prog. Brain Res. 82:1990;861-863.
204. Takami K., Matsuo A., Terai K., Walker D.G., McGeer E.G., McGeer P.L. Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease. Brain Res. 802:1998;89-97.
205. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J. Anat. 194:(pt. 1):1999;1-14.
206. A controlled trial of recombinant methionyl human BDNF in ALS. Neurology. 52:((7)):1999;1427-1433.
207. Thoenen H., Barde Y.A., Davies A.M., Johnson J.E. Neurotrophic factors and neuronal death. Ciba Found. Symp. 126:1987;82-95.
208. Thome J., Nara K., Foley P., Michel T., Gsell W., Retz W., Rosler M., Riederer P. Ciliary neurotrophic factor (CNTF) genotypes: influence on choline acetyltransferase (ChAT) and acetylcholine esterase (AchE) activities and neurotrophin 3 (NT3) concentration in human post mortem brain tissues. J. Hirnforsch. 38:(4):1997;443-451.
209. Thompson J., Doxakis E., Pinon L.G., Strachan P., Buj-Bello A., Wyatt S., Buchman V.L., Davis A.M. GFRalpha-4, a new GDNF family receptor. Mol. Cell. Neurosci. 11:(3):1998;117-126.
210. Thorns V., Masliah E. Evidence for neuroprotective effects of acidic fibroblast growth factor in Alzheimer disease. J Neuropathol. Exp. Neurol. 58:(3):1999;296-306.
211. Toledano A. Growth and aging factors in physiological senility and Alzheimer's disease. Rev. Neurol. 146:1997;1592-1602.
212. Tomac A., Lindqvist E., Lin L-F.H., Orgen S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
213. Tomac A., Widenfalk J., Lin L.F., Kohno T., Ebandel T., Hoffer B.J., Olson L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA. 92:(18):1995;8274-8278.
214. Tooyama I. Fibroblast growth factors (FGFs) in neurodegenerative disorders. Rinsho Shinkeigaku. 33:(12):1993;1270-1274.
215. Tooyama I., Kawamata T., Walker D. Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease. Neurology. 43:1993;372-376.
216. Treanor J.J., Goodman L., de Sauvage F., Stone D.M., Poulson K.T., Beck C.D., Gray C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:(6586):1996;80-83.
217. Trupp M., Arenas E., Fainzilber M., Nilsson A.S., Sieber B.A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumae U. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 381:(6585):1996;785-789.
218. Trupp M., Belluardo N., Funakoshi H., Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17:(10):1997;3554-3567.
219. Trupp M., Raynoschenk C., Bellurado N., Ibanez C.F. Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase. Mol. Cell. Neurosci. 11:(1/2):1998;47-63.
220. Tsujino H., Mansur K., Kiryu-Seo S., Namikawa K., Kitahara T., Tanabe K., Ochi T., Kiyama H. Discordant expression of c-Ret and glial cell line-derived neurotrophic factor receptor alpha-1 mRNAs in response to motor nerve injury in neonate rats. Brain Res. Mol. Brain Res. 70:(2):1999;298-303.
221. Tuszynski M.H., Sang H., Yoshida K., Gage F.H. Recombinant human nerve growth factor infusion prevents cholinergic neuronal degeneration in the adult primate brain. Ann. Neurol. 30:1991;625-636.
222. M.H. Tuszynski, H.S. U, D.G. Amaral, F.H. Gage, Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration, J. Neurosci. 10 (1990) 304-314.
223. Verity A.N., Wyatt T.L., Lee W., Hajos B., Baker P.A., Eglen R.M., Johnson R.M. Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. J. Neurosci. Res. 55:(2):1999;187-197.
224. Volpe B.T., Wildmann J., Altar C.A. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal/pallidial lesions. Neuroscience. 83:(3):1998;741-748.
225. Walker D.G., Beach T.G., Xu R., Lile J., Beck K.D., McGeer E.G., McGeer P.L. Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease. Brain Res. 792:(2):1998;207-217.
226. Walker D.G., Terai K., Mutsuo A., Beach T.G., McGeer E.G., McGeer P.L. Immunohistochenical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases. Brain Res. 794:1998;181-187.
227. Walton K.M. GDNF: a novel factor with therapeutic potential for neurodegenerative disorders. Mol. Neurobiol. 19:(1):1999;43-59.
228. Wang Y., Hagel C., Hamel W., Muller S., Kluwe L., Westphal M. TrkA, B and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma. Acta Neuropathol. (Berl.). 96:(4):1998;357-364.
229. Watanabe D., Yoshimura R., Khalil M., Yoshida K., Kishimoto T., Taga T., Kiyama H. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain. Eur. J. Neurosci. 8(8):1996;1630-1640.
230. Wartiovaara K., Hytonen M., Vuori M., Paulin L., Rinne J., Sariola H. Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease. Exp. Neurol. 152:(2):1998;307-309.
231. Wiese S., Digby M.R., Gunnersen J.M., Gotz R., Pei G., Holtmann B., Lowenthal J., Sendtner M. The anti-apoptotic protein ITA is essential for NGF-mediated survival of embryonic chick neurons. Nat. Neurosci. 2:(11):1999;978-983.
232. Wilcox B.J., Applegate M.D., Portera-Cailliau C., Koliatsos V.E. Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons. J. Comp. Neurol. 359:1995;573-585.
233. Winkler J., Thal L.J., Gage F.H., Fisher L.J. Cholinergic strategies for Alzheimer's disease. J. Mol. Med. 76:(8):1998;555-567.
234. White M.G., Hammond R.R., Sanders V.J., Bonaroti E.A., Mehta A.P., Wang G., Wiley C.A., Achim C.L. Neuron-enriched second trimester human cultures: growth factor response and in vivo graft survival. Cell Transplant. 8:(1):1999;59-73.
235. Woodbury D., Schaar D.G., Ramakrishnan L., Black I.B. Novel structure of the human GDNF gene. Brain Res. 803:(1-2):1998;95-104.
236. Wu C.K., Mesulam M.M., Geula C. Age-related loss of calbindin from human basal forebrain cholinergic neurons. Neuroreport. 8:(9-10):1997;2209-2213.
237. Yamada K., Nitta A., Hasegawa T., Fuji K., Hiramatsu M., Kameyama T., Furukawa Y., Hayashi K., Nabeshima T. Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease. Brain Res. Behav. Brain Res. 83:1997;117-122.
238. Yea X., Mehlenac P., Rabizadeha S., VanArsdalee T., Zhanga H., Shina H., Wanga J.J., Leoe E., Zapata J., Hauser C.A., Reede J.C., Bredesenai D.E. TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J. Biol. Chem. 274:(42):1999;30202-30208.
239. Yoshimoto Y., Lin Q., Collier T.J., Frim D.M., Breakfield X.O., Bohn M.C. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 691:1995;25-36.
240. Yu T., Scully S., Yu Y., Fox G.M., Jing S., Zhou R. Expression of GDNF family receptor components during development: implications in the mechanisms of interactions. J. Neurosci. 18:(12):1998;4684-4696.
241. Yuen E.C., Howe C.L., Li Y., Holtzman D.M., Mobley W.C. Nerve growth factor and the neurotrophic factor hypothesis. Brain Dev. 18:(5):1996;362-368.
242. Yuen E.C., Mobly W.C. Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 40:1996;346-354.
243. Zhao B., Schwartz J.P. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J. Neurosci. Res. 52:(1):1998;7-16.